Century Therapeutics Ownership | Who Owns Century Therapeutics?


OverviewForecastFinancialsChart

Century Therapeutics Ownership Summary


Century Therapeutics is owned by 15.63% institutional investors, 25.94% insiders, and 58.43% retail investors. Ra capital management is the largest institutional shareholder, holding 20.51% of IPSC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.42% of its assets in Century Therapeutics shares.

IPSC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCentury Therapeutics15.63%25.94%58.43%
SectorHealthcare Stocks 232.80%10.63%-143.43%
IndustryBiotech Stocks 379.48%10.37%-289.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management17.75M20.51%$40.13M
Tcg crossover management17.75M20.51%$39.02M
Versant venture management12.17M14.06%$27.50M
Deep track capital, lp9.49M10.96%$21.44M
Rtw investments, lp8.70M10.05%$19.65M
Vr adviser8.70M10.05%$19.65M
Commodore capital lp8.70M10.05%$19.65M
Boxer capital4.90M7.87%$12.50M
Point72 asset management5.96M6.89%$13.48M
Balyasny asset management5.02M5.80%$11.34M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Versant venture management12.17M19.44%$27.50M
Syncona portfolio1.21M10.66%$2.74M
Dafna capital management2.43M1.25%$5.50M
Commodore capital lp8.70M1.14%$19.65M
Tcg crossover management17.75M1.12%$39.02M
Vr adviser8.70M0.73%$19.65M
Boxer capital4.90M0.66%$12.50M
Ra capital management17.75M0.43%$40.13M
Deep track capital, lp9.49M0.35%$21.44M
Cannon global investment management49.00K0.22%$110.74K

Top Buyers

HolderShares% AssetsChange
Ra capital management17.75M0.43%17.75M
Tcg crossover management17.75M1.12%17.75M
Versant venture management12.17M19.44%12.17M
Deep track capital, lp9.49M0.35%9.49M
Commodore capital lp8.70M1.14%8.70M

Top Sellers

HolderShares% AssetsChange
Bain capital life sciences investors3.54M0.12%-1.87M
Avidity partners management lp---1.22M
Acadian asset management278.07K0.00%-939.03K
Octagon capital advisors lp---666.83K
Renaissance906.83K0.00%-442.37K

New Positions

HolderShares% AssetsChangeValue
Tcg crossover management17.75M1.12%17.75M$39.02M
Ra capital management17.75M0.43%17.75M$40.13M
Versant venture management12.17M19.44%12.17M$27.50M
Deep track capital, lp9.49M0.35%9.49M$21.44M
Vr adviser8.70M0.73%8.70M$19.65M

Sold Out

HolderChange
Citigroup-1.00
Ifp advisors-6.00
Nelson, van denburg & campbell wealth management group-6.00
Capital performance advisors llp-12.00
Eversource wealth advisors-28.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202532-39.62%13,517,957-33.34%152.83%12-25.00%9-60.87%
Sep 30, 202551-16.39%20,279,909-7.85%233.59%15-55.88%2321.05%
Jun 30, 202566-4.35%22,628,552-20.19%262.42%3760.87%20-31.03%
Mar 31, 202570-5.41%29,566,395-18.77%341.86%23-48.89%29190.00%
Dec 31, 2024748.82%36,399,688-8.20%421.96%4441.94%10-37.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.34M2.42%2.83M
Fidelity Growth Compy Commingled Pl O1.22M1.45%-96.60K
Syncona Ord1.21M1.43%212.28K
Vanguard Institutional Extnd Mkt Idx Tr1.21M0.67%665.55K
Fidelity Small Cap Index480.13K0.56%-
State St Russell Sm/Mid Cp® Indx NL Cl C366.83K0.43%-
State St Russell Sm/Mid Cp® Indx SL Cl I366.83K0.43%-
Fidelity Extended Market Index577.70K0.32%327.99K
Federated Hermes Kaufmann Growth267.75K0.32%-
Federated Hermes Kaufmann R267.75K0.32%-

Recent Insider Transactions


DateNameRoleActivityValue
May 04, 2026Carr Douglas SVP Finance & OperationsSell$618.02
Mar 12, 2026Carr Douglas SVP Finance & OperationsSell$17.95K
Mar 12, 2026Russotti Gregory See RemarksSell$25.68K
Mar 09, 2026Russotti Gregory See RemarksSell$1.21K
Feb 03, 2026Carr Douglas SVP Finance & OperationsSell$588.51

Insider Transactions Trends


DateBuySell
2026 Q2-1
2026 Q1-4
2025 Q435
2025 Q3-4
2025 Q2-7

IPSC Ownership FAQ


Who Owns Century Therapeutics?

Century Therapeutics shareholders are primarily institutional investors at 15.63%, followed by 25.94% insiders and 58.43% retail investors. The average institutional ownership in Century Therapeutics's industry, Biotech Stocks , is 379.48%, which Century Therapeutics falls below.

Who owns the most shares of Century Therapeutics?

Century Therapeutics’s largest shareholders are Ra capital management (17.75M shares, 20.51%), Tcg crossover management (17.75M shares, 20.51%), and Versant venture management (12.17M shares, 14.06%). Together, they hold 55.08% of Century Therapeutics’s total shares outstanding.

Does Blackrock own Century Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Century Therapeutics.

Who is Century Therapeutics’s biggest shareholder by percentage of total assets invested?

Versant venture management is Century Therapeutics’s biggest shareholder by percentage of total assets invested, with 19.44% of its assets in 12.17M Century Therapeutics shares, valued at 27.5M$.

Who is the top mutual fund holder of Century Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Century Therapeutics shares, with 2.42% of its total shares outstanding invested in 4.34M Century Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools